nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—EDNRA—GPCRs, Other—P2RY11—narcolepsy	0.0509	0.0509	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0296	0.0296	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0296	0.0296	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0292	0.0292	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0292	0.0292	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—P2RY11—narcolepsy	0.0286	0.0286	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0265	0.0265	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0265	0.0265	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0256	0.0256	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HCRT—narcolepsy	0.0243	0.0243	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—HCRT—narcolepsy	0.024	0.024	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0221	0.0221	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0218	0.0218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—PENK—narcolepsy	0.0214	0.0214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0196	0.0196	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0196	0.0196	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0189	0.0189	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—TRH—narcolepsy	0.0184	0.0184	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—TRH—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HCRTR2—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HCRTR1—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—P2RY11—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—HTR2A—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—NPS—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—TAC1—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—NPS—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HCRT—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.012	0.012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.012	0.012	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—PENK—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—TRH—narcolepsy	0.0093	0.0093	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00887	0.00887	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HCRTR2—narcolepsy	0.00844	0.00844	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HCRTR1—narcolepsy	0.00844	0.00844	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—P2RY11—narcolepsy	0.00815	0.00815	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HRH3—narcolepsy	0.00815	0.00815	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HTR2A—narcolepsy	0.00806	0.00806	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HCRTR2—narcolepsy	0.00767	0.00767	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HCRTR1—narcolepsy	0.00767	0.00767	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—P2RY11—narcolepsy	0.0074	0.0074	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00721	0.00721	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HCRT—narcolepsy	0.00693	0.00693	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—TAC1—narcolepsy	0.00676	0.00676	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPS—narcolepsy	0.00676	0.00676	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HCRT—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00623	0.00623	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PENK—narcolepsy	0.00618	0.00618	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PENK—narcolepsy	0.00561	0.00561	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00534	0.00534	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TRH—narcolepsy	0.00525	0.00525	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TRH—narcolepsy	0.00477	0.00477	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HRH3—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HCRTR1—narcolepsy	0.00453	0.00453	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HCRTR2—narcolepsy	0.00453	0.00453	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—P2RY11—narcolepsy	0.00437	0.00437	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRH3—narcolepsy	0.00418	0.00418	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR2A—narcolepsy	0.00406	0.00406	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—TAC1—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPS—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HCRT—narcolepsy	0.00372	0.00372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—TAC1—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPS—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PENK—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TRH—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRH3—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR2A—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2A—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TAC1—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPS—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00202	0.00202	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CHKB—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2A—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CPT1B—narcolepsy	0.0009	0.0009	CbGpPWpGaD
